John M Allen

John M Allen, Pharm.D., BCPS, BCCCP, FCCM, FCCP

Associate Dean For Accessibility, Belonging And Community Health; Clinical Associate Professor

Department: PH-DISTANCE CAMPUS-ORLANDO
Business Phone: (407) 313-7006
Business Email: john.allen@cop.ufl.edu

About John M Allen

John M. Allen, Pharm.D., BCPS, BCCCP, FCCM, FCCP is the UF College of Pharmacy’s associate dean for accessibility, belonging and community health, and a clinical associate professor at the college’s Orlando campus. Born and raised in Philadelphia, Dr. Allen joined the college in 2018. Dr. Allen’s professional areas of interest include health equity, antimicrobial stewardship in the intensive care unit, antibiotic dosing in sepsis, and treatment of multi-drug resistant infections in critically ill patients.

Dr. Allen graduated with his Doctor of Pharmacy degree from Florida A&M University in Tallahassee, FL. He then completed a PGY-1 residency, followed by a PGY-2 Critical Care residency at Tampa General Hospital, in Tampa, FL. Dr. Allen is a dual board-certified pharmacist in critical care, and pharmacotherapy.

Dr. Allen is an active member of the Society of Critical Care Medicine, American College of Clinical Pharmacy, Society of Infectious Diseases Pharmacists and the Florida Society of Health-System Pharmacists and has been appointed to committees within all of these organizations. In 2017, Dr. Allen received the prestigious honor of induction as a Fellow of the American College of Critical Care Medicine, which honors individuals whose achievements and contributions demonstrate personal commitment to critical care excellence, a distinction at the time of his induction bestowed upon seven pharmacists in the state of Florida.

Prior to his appointment at the University of Florida, Dr. Allen has held a variety of diverse administrative experiences including serving as a pharmacy clinical coordinator, pharmacy residency program director, and director of infectious diseases pharmacy for a 16-hospital system. In his free time, Dr. Allen enjoys watching anything with four wheels going fast, traveling, and spending time with his wife and three children.

Accomplishments

Minority Faculty Scholar in Cancer Research Award
2022 · American Association for Cancer Research
Presidential Citation
2021 · Society of Critical Care Medicine
Elected Fellow
2020 · American College of Clinical Pharmacy
Exemplary Teacher Award
2020 · University of Florida College of Pharmacy
Outstanding Student Organization Advisor
2020 · University of Florida College of Pharmacy
Mentored Research Investigator Training (MeRIT) Scholarship Award
2019 · American College of Clinical Pharmacy Critical Care Practice Research Network
Presidential Citation
2018 · Society of Critical Care Medicine
Elected Fellow
2017 · American College of Critical Care Medicine
Presidential Citation
2015 · Society of Critical Care Medicine

Teaching Profile

Courses Taught
2018,2020
PHA5878C Pt Care 3: Cv and Pulm
2018-2020
PHA5782C Patient Care 2
2019-2021
PHA5876C Pt Care 8 Complex Pts
2019,2021-2023
PHA5607 Crit Care Pharmacy
2019,2021
PHA5787C Pt Care 5: Endo
2019
PHA5164L Prof Skills Lab Iv
2018
PHA5163L Prac Skills Lab III
2018
PHA5788 Pharmacotherapy 6
2021
PHA5784C Pt Care 4: GI and Renal
2021
PHA5787 Pharmacotherapy 5
2021-2024
PHA5007 Pharm and Pop Health
2022
PHA5933 Select Top Pharmacy
2023
PHA5726 Health Disparities, Health Equity, and Pharmacy

Board Certifications

  • Board Certified Critical Care Pharmacist
    Board of Pharmacy Specialties
  • Board Certified Pharmacotherapy Specialist
    Board of Pharmacy Specialties

Clinical Profile

Areas of Interest
  • Pancreatic cancer
  • Sepsis
  • Septic shock

Research Profile

Areas of Interest
  • Antibiotic resistance
  • Cancer survivorship
  • Health disparities and Social determinants of health
  • Health disparities and vulnerable populations
  • Sepsis
Open Researcher and Contributor ID (ORCID)

0000-0002-0033-4508

Publications

2023
Community Champions: The Crucial Contribution of an Independent Pharmacy in COVID-19 Vaccination Efforts in an Underserved Community
International Journal of Environmental Research and Public Health. 20(19) [DOI] 10.3390/ijerph20196881. [PMID] 37835151.
2023
Curricular changes in times of crisis: Lessons learned
Currents in Pharmacy Teaching and Learning. [DOI] 10.1016/j.cptl.2023.02.014.
2023
Didactic education for the deaf or hard of hearing learner in a pharmacy curriculum: Commentary.
Currents in pharmacy teaching & learning. 15(4):329-333 [DOI] 10.1016/j.cptl.2023.04.013. [PMID] 37105797.
2023
Disparities in the use of pain medication in patients with pancreatic cancer: Focus on racial and ethnic minorities
Cancer Epidemiology, Biomarkers & Prevention. 32(1_Supplement):A026-A026 [DOI] 10.1158/1538-7755.disp22-a026.
2023
Evaluation of psychotropic medication usage patterns in patients with pancreatic cancer by race/ethnicity
Cancer Epidemiology, Biomarkers & Prevention. 32(1_Supplement):A027-A027 [DOI] 10.1158/1538-7755.disp22-a027.
2023
Evaluation of racial and ethnic psychotropic medication use among patients with colorectal cancer
Cancer Research. 83(7_Supplement):1932-1932 [DOI] 10.1158/1538-7445.am2023-1932.
2023
Exploring racial and ethnic disparities in pain medication use in patients with colorectal cancer
Cancer Research. 83(7_Supplement):754-754 [DOI] 10.1158/1538-7445.am2023-754.
2023
Exploring trends in social vulnerability for pharmacy students at a large public university
American Journal of Pharmaceutical Education. [DOI] 10.1016/j.ajpe.2023.100551. [PMID] 37336326.
2023
Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes.
Cancer control : journal of the Moffitt Cancer Center. 30 [DOI] 10.1177/10732748231197878. [PMID] 37703814.
2023
Implementing innovative teaching strategies to promote student academic engagement in a critical care elective
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(9):1022-1029 [DOI] 10.1002/jac5.1839.
2023
Pharmacogenetics of pancreatic ductal adenocarcinoma: A review of racial disparities
Cancer Epidemiology, Biomarkers & Prevention. 32(1_Supplement):C026-C026 [DOI] 10.1158/1538-7755.disp22-c026.
2023
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
Journal of the National Medical Association. [DOI] 10.1016/j.jnma.2023.01.008.
2023
Unraveling racial disparities in supportive care medication use among end-of-life pancreatic cancer patients: Focus on pain management and psychiatric therapies.
Cancer epidemiology, biomarkers & prevention. 32(12):1675-1682 [DOI] 10.1158/1055-9965.EPI-23-0251.
2022
A Scoping Review on the Relationship between Race/Ethnicity and the Receipt of Supportive Care Medications during Cancer Treatment: Implications for the Clinical Pharmacist
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5(12):1284-1296 [DOI] 10.1002/jac5.1727. [PMID] 36844700.
2022
Cognitive Testing of PAINReportIt-Spanish in Monolingual Hispanic Adults
Cancer Nursing. Publish Ahead of Print [DOI] 10.1097/ncc.0000000000001123.
2022
Evaluation of attitudes, beliefs and influences and their impact on HPV vaccination rates among minority health science students
Cancer Epidemiology, Biomarkers & Prevention. 31(1_Supplement):PO-270 [DOI] 10.1158/1538-7755.disp21-po-270.
2022
EVALUATION OF BLACK-WHITE RACIAL DISPARITIES IN SEPSIS PATIENTS TREATED WITH PIPERACILLIN-TAZOBACTAM
Critical Care Medicine. 50(1):720-720 [DOI] 10.1097/01.ccm.0000812064.96012.8a.
2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing after Percutaneous Coronary Intervention.
Clinical pharmacology and therapeutics. 113(3):615-623 [DOI] 10.1002/cpt.2776. [PMID] 36306392.
2022
Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study.
The Annals of pharmacotherapy. 57(6):10600280221125919-661 [DOI] 10.1177/10600280221125919. [PMID] 36154486.
2022
Mentorship in a Professional Pharmacy Association: A Tale of Two Programs
Journal of Faculty Development. 36(1):82-95
2022
Pharmacoequity and the clinical pharmacist: Why not us, why not now!
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5(8):790-792 [DOI] 10.1002/jac5.1680.
2022
Pharmacokinetics in patients requiring renal replacement therapy
Atkinson's Principles of Clinical Pharmacology. 73-90 [DOI] 10.1016/b978-0-12-819869-8.00018-5.
2022
Pharmacy student self-assessment of strength of residency candidacy compared to clinical faculty.
Currents in pharmacy teaching & learning. 14(3):304-309 [DOI] 10.1016/j.cptl.2022.01.017. [PMID] 35307089.
2022
The ReTOOL training program for underrepresented minority students: Best practices for virtual training in midst of COVID-19
Cancer Epidemiology, Biomarkers & Prevention. 31(1_Supplement):PO-056 [DOI] 10.1158/1538-7755.disp21-po-056.
2021
Addressing challenges of providing remote inpatient clinical pharmacy services
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. [DOI] 10.1002/jac5.1553.
2021
Comparison of Common Piperacillin-Tazobactam Dosing Strategies in Patients With Septic Shock
Critical Care Medicine. 49(1):423-423 [DOI] 10.1097/01.ccm.0000729300.19058.54.
2021
Impact of a Multimedia Approach to Rapid Response Team Training in a Pharmacy Critical Care Elective
Critical Care Medicine. 49(1):443-443 [DOI] 10.1097/01.ccm.0000729456.22937.2f.
2021
Impact of supplemental individual verbal defense on confidence, engagement, and performance in a team-based learning therapeutics course.
Currents in pharmacy teaching & learning. 13(2):152-158 [DOI] 10.1016/j.cptl.2020.09.010. [PMID] 33454072.
2021
Ten recommendations to increase Black representation within pharmacy organization leadership.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 78(10):896-902 [DOI] 10.1093/ajhp/zxab077. [PMID] 33954422.
2020
161: Beta-lactam-induced platelet drop in critically ill patients
Journal of the American College of Clinical Pharmacy. 3(8):1596-1597
2020
531: Impact of individual antimicrobial stewardship interventions in the intensive care unit: A systematic review and meta-analysis
Journal of the American College of Clinical Phamacy. 3(8):1682-1683
2020
59: MeRIT project: Impact of early antibiotic renal dosing in septic shock patients utilizing real-world evidence
Journal of the American College of Clinical Pharmacy. 3(8):1550-1551
2020
COVID-19 Therapeutics: Making Sense of It All.
AACN advanced critical care. 31(3):239-249 [DOI] 10.4037/aacnacc2020792. [PMID] 32668460.
2020
Impact of antibiotic exposure on the overall survival in patients receiving immune checkpoint inhibitors: Does race matter?
Cancer Epidemiology, Biomarkers, and Prevention. 29(6 Suppl_2) [DOI] 10.1158/1538-7755.disp19-d057.
2019
Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
Clinical therapeutics. 41(12):2594-2610 [DOI] 10.1016/j.clinthera.2019.09.014. [PMID] 31668356.
2019
Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis
Infectious Diseases and Therapy. 8(4):671-686 [DOI] 10.1007/s40121-019-00259-4. [PMID] 31392580.
2019
Effect of prescriber peer comparison reports on fluoroquinolone use across a 16‐facility community hospital system
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(5):502-508 [DOI] 10.1002/jac5.1106.
2019
Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids.
The Annals of pharmacotherapy. 53(4):385-395 [DOI] 10.1177/1060028018812940.
2015
Green urine in the intensive care unit: is this clinically relevant?
The American surgeon. 81(1):E32-3 [PMID] 25569058.
2015
Major publications in the critical care pharmacotherapy literature: January-December 2013.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 72(3):224-36 [DOI] 10.2146/ajhp140241. [PMID] 25596607.
2015
Standard Dosing of Enoxaparin for Venous Thromboembolism Prophylaxis Is Not Sufficient for Most Patients Within a Trauma Intensive Care Unit.
The American surgeon. 81(9):889-92 [PMID] 26350667.
2014
Pharmacogenomics in the intensive care unit: focus on potential implications for clinical practice.
Recent patents on biotechnology. 8(2):116-22 [PMID] 25185987.
2014
Understanding vasoactive medications: focus on pharmacology and effective titration.
Journal of infusion nursing : the official publication of the Infusion Nurses Society. 37(2):82-6 [DOI] 10.1097/NAN.0000000000000022. [PMID] 24583937.
2013
Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
American journal of surgery. 205(3):255-8; discussion 258 [DOI] 10.1016/j.amjsurg.2012.10.011. [PMID] 23375761.
2013
Ventriculoperitoneal shunt infections in adult patients.
AACN advanced critical care. 24(1):6-12; quiz 13 [DOI] 10.1097/NCI.0b013e31827be1d1. [PMID] 23343806.
2012
Prevention, recognition, and management of delirium in the intensive care unit.
AACN advanced critical care. 23(1):5-11; quiz 12 [DOI] 10.1097/NCI.0b013e31822c3633. [PMID] 22290083.
2012
Vasoactive substances and their effects on nutrition in the critically ill patient.
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 27(3):335-9 [DOI] 10.1177/0884533612443989. [PMID] 22504108.
2011
Evaluation of Recombinant Factor VIIa Off-Label Use at an Acute Care Hospital with Established Guidelines for Use
Hospital Pharmacy. 46(3):173-179 [DOI] 10.1310/hpj4603-173.

Grants

Sep 2023 ACTIVE
2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center
Role: Other
Funding: NATL INST OF HLTH NCI
Feb 2023 ACTIVE
Disparities of Alzheimer's disease progression in sexual and gender minorities
Role: Co-Investigator
Funding: NATL INST OF HLTH NIA
Jul 2022 ACTIVE
All of Us Consortium of CTSA Community Engagement Programs
Role: Faculty
Funding: NATL INST OF HLTH OD
Jun 2021 – May 2023
Florida Cancer ReTOOL Program for Underrepresented Minority Students
Role: Principal Investigator
Funding: MAYO CLINIC via NATL INST OF HLTH NCI
Sep 2018 – Aug 2023
2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI

Education

Post Graduate Year 2 (PGY-2) Critical Care Pharmacy Residency
2010-2011 · Tampa General Hospital
Post Graduate Year 1 (PGY-1) Pharmacy Residency
2009-2010 · Tampa General Hospital
Pharm.D.
2003-2009 · Florida A&M University

Contact Details

Phones:
Business:
(407) 313-7006
Emails:
Addresses: